One Rare Mother’s Quest to Rewrite Her Son’s Future with a Gene Therapy

Amber Freed transformed the shock of her son’s diagnosis with an ultra-rare neurodevelopmental disorder into a determined campaign for gene therapy. With no clinical roadmap, sparse literature, and doctors offering only symptomatic care, she taught herself biology basics, established a nonprofit, and assembled a scientific team. She focused on gene replacement therapy as the most viable path, and son became the first patient treated in a clinical trial of the experimental gene therapy last September. We spoke to Freed, founder and CEO of SLC6A1 Connect, about how a parent with no scientific background catalyzed the development of the first experimental gene therapy for SLC6A1-related disorder, mobilized scientists, and what other rare disease communities can learn from her journey.

You can listen to One Rare Mother’s Quest to Rewrite Her Son’s Future with a Gene Therapy online on Radio and Podcast. Open the player on this page to stream the available audio.

One Rare Mother’s Quest to Rewrite Her Son’s Future with a Gene Therapy is an episode from RARECast by RARECast.

This episode is 00:35:46 long.

This episode was published on Jan 15, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from RARECast when more episodes are available from the podcast feed.